How much did Beyang Therapeutics raise?

Beyang Therapeutics raised $30M at Series A, announced 12 August 2026.

Who founded Beyang Therapeutics?

Qiyue Hu is Founder & CEO of Beyang Therapeutics.

What does Beyang Therapeutics do?

Beyang Therapeutics operates in HealthTech and is based in China.

FundedStartupsDaily / HealthTech / Beyang Therapeutics

Beyang Therapeutics raises $30M

Beyang Therapeutics announced a Series A round of $30M on 12 August 2026. The company operates in HealthTech and is based in China. It was founded by Qiyue Hu, Founder & CEO.

Raised

$30M

Stage

Series A

Industry

HealthTech

Country

China

Founder

Qiyue Hu

Founder & CEO, Beyang Therapeutics

LinkedIn profile beyangtx.com

Outreach angles

-Founded and leads Beyang Therapeutics as CEO, building the ExCEED AI drug discovery platform.
-Built Beyang's pipeline to include eye drop treatments for fundus diseases and Menin inhibitors for neuro-oncology.
-Closed a nearly $30 million oversubscribed Series A to advance Beyang's AI-driven drug R&D platform.